NCT04828902

Brief Summary

Postoperative delirium is an acute syndrome of mental deterioration characterized by acute onset and fluctuating course during the day. Very frequent delirium is a presage of other serious comorbidities i.e.: sepsis, acute kidney injury, circulatory and/or respiratory failure. A detailed knowledge of symptoms and early diagnose of delirium increase the chances of early therapy. To what extent the occurrence of postoperative delirium influences hospital therapy in the Cardiac Surgical Postoperative ICU in University Clinical Centre in Gdańsk is unknown so far.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 2, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2022

Completed
Last Updated

April 15, 2021

Status Verified

April 1, 2021

Enrollment Period

12 months

First QC Date

March 21, 2021

Last Update Submit

April 12, 2021

Conditions

Keywords

postoperative deliriumcardiac surgeryCovid19

Outcome Measures

Primary Outcomes (3)

  • Delirium incidence and risk

    Incidence and risk of postoperative delirium

    Through hospitalisation in Postop-ICU - an average of 2 days

  • Risk factors of delirium.

    collected will be known risk factors of delirium: schedule type, age, arterial hypertension, atrial fibrillation, BMI, ACE/ARBs therapy, hearing loss, dementia, peripheral artery disease, myocardial infarction, depression, diabetes, COVID19 and/or vaccination for it; and outcome data: hospital-LOS, prolonged sedation, antipsychotic therapy, surgical reintervention, direct coercion, length of mechanical ventilation, number of tracheal intubations, length of consciousness disorders, blood product transfusions, cardiopulmonary resuscitation, renal replacement therapy, mechanical circulatory support, duration of catecholamine support, ICU readmissions, new antibiotic therapies, 30-day mortality.

    Through hospitalisation in Postop-ICU - an average of 2 days

  • Association between delirium and length of stay in ICU (LOS-ICU).

    Association between delirium and length of stay in ICU (LOS-ICU).

    Through hospitalisation in Postop-ICU - an average of 2 days

Secondary Outcomes (12)

  • DOSS

    Through hospitalisation in Postop-ICU - an average of 2 days

  • Hospital-LOS

    Through hospitalisation in Postop-ICU - an average of 2 days

  • Prolonged sedation, antipsychotic therapy and surgical re-intervention.

    Through hospitalisation in Postop-ICU - an average of 2 days

  • Hours on ventilator.

    Through hospitalisation in Postop-ICU - an average of 2 days

  • Intubations

    Through hospitalisation in Postop-ICU - an average of 2 days

  • +7 more secondary outcomes

Interventions

Any heart surgery on or without cardiopulmonary bypass performed under general anesthesia in the Cardiac Surgical Department, Medical University of Gdańsk.

Also known as: cabg, valve surgery, aorta surgery, heart transplant, other cardiac surgery

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsGender will be reported as declared by the subjects.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients undergoing elective/emergency cardiac surgery will be considered eligible.

You may qualify if:

  • Adult patients (\>18 y.a.), undergoing cardiac surgery, who will sign an informed consent to participate in the study.

You may not qualify if:

  • Deny to sign or absence of an informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cadiac Anesthesiology, Medical University of Gdańsk

Gdansk, Pomeranian Voivodeship, 80-211, Poland

RECRUITING

MeSH Terms

Conditions

Emergence DeliriumCOVID-19

Interventions

Cardiac Surgical ProceduresCoronary Artery BypassHeart Transplantation

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Cardiovascular Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical ProceduresMyocardial RevascularizationVascular GraftingVascular Surgical ProceduresOrgan TransplantationTransplantation

Study Officials

  • Romuald Lango, Prof.dr.hab.

    Medical University of Gdańsk, Department of Cardiac Anesthesiology

    STUDY CHAIR
  • Maciej Kowalik, Dr hab.

    Medical University of Gdańsk, Department of Cardiac Anesthesiology

    STUDY DIRECTOR
  • Pawel Kozak, Mgr. Piel.

    Medical University of Gdańsk, Department of Cardiac Anesthesiology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maciej M Kowalik, Dr. hab.

CONTACT

Paweł Kozak, Mgr. Piel.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Promotor, Dr hab. n. med. Maciej Michał Kowalik

Study Record Dates

First Submitted

March 21, 2021

First Posted

April 2, 2021

Study Start

February 1, 2021

Primary Completion

January 31, 2022

Study Completion

August 31, 2022

Last Updated

April 15, 2021

Record last verified: 2021-04

Locations